ClinVar Genomic variation as it relates to human health
NM_000265.7(NCF1):c.75_76del (p.Tyr26fs)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000265.7(NCF1):c.75_76del (p.Tyr26fs)
Variation ID: 2249 Accession: VCV000002249.35
- Type and length
-
Microsatellite, 2 bp
- Location
-
Cytogenetic: 7q11.23 7: 74777267-74777268 (GRCh38) [ NCBI UCSC ] 7: 74191613-74191614 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Apr 4, 2013 Oct 20, 2024 Mar 1, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000265.7:c.75_76del MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000256.4:p.Tyr26fs frameshift NM_000265.7:c.75_76delGT MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NC_000007.14:g.74777267GT[1] NC_000007.13:g.74191613GT[1] NG_009078.2:g.8304GT[1] NG_042249.1:g.43431GT[1] LRG_87:g.8304GT[1] LRG_87t1:c.75_76del LRG_87p1:p.Tyr26fs - Protein change
- Y26fs
- Other names
- -
- Canonical SPDI
- NC_000007.14:74777266:GTGT:GT
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
NCF1 | No evidence available | No evidence available |
GRCh38 GRCh37 |
4 | 118 | |
LOC106029312 | - | - | - | GRCh38 | - | 112 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (4) |
criteria provided, multiple submitters, no conflicts
|
Dec 13, 2023 | RCV000002337.11 | |
Pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Mar 1, 2024 | RCV001090891.25 | |
Pathogenic (1) |
no assertion criteria provided
|
May 1, 2022 | RCV002283438.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Mar 27, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV001985174.2
First in ClinVar: Nov 06, 2021 Last updated: Mar 04, 2023 |
Comment:
Is the most common cause of autosomal recessive chronic granulomatous disease (CGD); has a carrier frequency of 1:250 in the population (Leiding et al., 2012); … (more)
Is the most common cause of autosomal recessive chronic granulomatous disease (CGD); has a carrier frequency of 1:250 in the population (Leiding et al., 2012); Accounts for more than 95% of pathogenic variants in the NCF1 gene (Noack et al., 2001); Arises from a recurrent gene conversion event between NCF1 and flanking pseudogenes containing the dinucleotide deletion (Leiding et al., 2012); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; No reliable data available from control populations to assess the frequency of this variant as the variant is pseudogene-derived; This variant is associated with the following publications: (PMID: 22138397, 22876374, 10706888, 2011585, 26409780, 27699571, 27699569, 27701760, 28130637, 29560547, 11133775, 8147881, 30651282, 30470980, 30409207, 30319683, 31631731, 31482473, 31813112, 32040803, 33365035) (less)
|
|
Pathogenic
(Dec 13, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1
Affected status: unknown
Allele origin:
unknown
|
Baylor Genetics
Accession: SCV005049772.1
First in ClinVar: Jun 09, 2024 Last updated: Jun 09, 2024 |
|
|
Pathogenic
(Apr 22, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1
Affected status: yes
Allele origin:
germline
|
Molecular Genetics, Royal Melbourne Hospital
Additional submitter:
Shariant Australia, Australian Genomics
Accession: SCV002503741.2
First in ClinVar: Apr 28, 2022 Last updated: Apr 15, 2024 |
Comment:
This sequence change is a deletion of 2 bp in exon 2 (of 11) of NCF1 that is predicted to create a premature termination codon … (more)
This sequence change is a deletion of 2 bp in exon 2 (of 11) of NCF1 that is predicted to create a premature termination codon at position 51, p.(Tyr26Hisfs*26). It is expected to result in nonsense-mediated decay, and loss of function is an established mechanism of disease for this gene (PVS1; ClinVar). The variant does not pass quality control in the gnomAD dataset, and thus cannot be assessed for population frequency (gnomAD v2.1, v3.0). Homozygosity of this variant is the most common cause of chronic granulomatous disease (CGD) due to deficiency of NCF1, produced by a recombination event between NCF1 & pseudogenes (PMID: 9329953). It has been identified in the homozygous and to a lesser degree compound heterozygous state with a second pathogenic allele in multiple CGD cases, and segregation with disease has been reported in over 12 families (PM3_VeryStrong, PP1_Strong; examples in PMID: 11133775, 16972229, 21190454). Based on the classification scheme RMH ACMG Guidelines v1.2.1, this variant is classified as PATHOGENIC. Following criteria are met: PVS1, PM3_VeryStrong, PP1_Strong. (less)
|
|
Pathogenic
(Mar 01, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
CeGaT Center for Human Genetics Tuebingen
Accession: SCV001246653.26
First in ClinVar: May 12, 2020 Last updated: Oct 20, 2024 |
Comment:
NCF1: PVS1, PM2
Number of individuals with the variant: 5
|
|
pathologic
(Aug 09, 2012)
|
no assertion criteria provided
Method: curation
|
Chronic Granulomatous Disease
Affected status: not provided
Allele origin:
not provided
|
GeneReviews
Accession: SCV000054520.1
First in ClinVar: Apr 04, 2013 Last updated: Apr 04, 2013 |
Comment:
Converted during submission to Pathogenic.
|
|
Pathogenic
(Jan 01, 2001)
|
no assertion criteria provided
Method: literature only
|
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 1
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000022495.5
First in ClinVar: Apr 04, 2013 Last updated: Aug 01, 2020 |
Comment on evidence:
In 3 unrelated cases of autosomal recessive chronic granulomatous disease-1 (CGD1; 233700), Casimir et al. (1991) identified a homozygous 2-bp deletion (c.75delGT) at a GTGT … (more)
In 3 unrelated cases of autosomal recessive chronic granulomatous disease-1 (CGD1; 233700), Casimir et al. (1991) identified a homozygous 2-bp deletion (c.75delGT) at a GTGT tandem repeat in the NCF1 gene, corresponding to the acceptor site of the first intron-exon junction (between IVS1 and exon 2). The authors suggested that slippage of the DNA duplex at this site may contribute to the high frequency of defects in this gene. In 2 unrelated patients (KS and SR) with CGD, Volpp and Lin (1993) identified a c.75delGT mutation in the NCF1 gene, resulting in a frameshift and premature termination at base 165. Patient KS was homozygous for the GT deletion, which occurred within the sequence TATGTGTA (bases 70-78). The other patient (SR) was compound heterozygous for c.75delGT and a 1-bp deletion (c.502delG; 608512.0002), which results in a frameshift and premature termination at base 605. Patient SR had previously been reported by Clark and Klebanoff (1978). Volpp and Lin (1993) demonstrated that the transfection of NCF1 cDNA into p47-phox-deficient cell lines resulted in the generation of normal levels of superoxide and readily detectable cytosolic enzyme. Gorlach et al. (1997) found that in each of 34 consecutive unrelated normal individuals, both the normal and mutant delta-GT sequences were present in genomic DNA. Further study revealed that this finding was due to the p47-phox pseudogene containing the delta-GT mutation. This close linkage, together with the presence within each gene of multiple recombination hotspots, suggested that the predominance of the delta-GT mutation in this autosomal recessive form of CGD is caused by recombination events between the wildtype gene and the pseudogene(s). Gene conversion events between homologous genes and their pseudogenes had been described in the pathogenesis of several genetic disorders, such as 21-hydroxylase deficiency (201910), von Willebrand disease (193400), and Gaucher disease (230800). Roesler et al. (2000) performed sequence analysis of 28 unrelated, racially diverse patients with the p47-phox-deficient form of CGD and 37 healthy individuals. In 25 patients, the CGD deletion in exon 2 was present in all alleles. Three patients and all healthy individuals contained GTGT and delta-GT sequences, the latter being a characteristic of the NCF1 pseudogene. A total of 22 patients carried additional pseudogene-specific intronic sequences on all alleles, either only in intron 1 or in intron 1 and intron 2, which led to different types of chimeric DNA strands. Roesler et al. (2000) concluded that recombination events between the NCF1 gene and its highly homologous pseudogenes result in the incorporation of delta-GT into the NCF1 gene, thereby leading to the high frequency of GT deletion in CGD patients with the p47-phox-deficient form. Unlike other CGD subtypes, in which there is great heterogeneity among mutations, 97% of affected alleles in patients with p47-phox deficiency carry the 2-bp deletion in the NCF1 gene (Noack et al., 2001). (less)
|
|
Pathogenic
(May 01, 2022)
|
no assertion criteria provided
Method: clinical testing
|
Granulomatous disease, chronic, X-linked
Affected status: yes
Allele origin:
germline
|
Clinic of Clinical Immunology with Stem Cell Bank, Expert Centre for Rare Diseases - PID, University Hospital "Alexandrovska"
Accession: SCV002573423.1
First in ClinVar: Sep 17, 2022 Last updated: Sep 17, 2022 |
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Chronic Granulomatous Disease. | Adam MP | - | 2022 | PMID: 22876374 |
Residual NADPH oxidase and survival in chronic granulomatous disease. | Kuhns DB | The New England journal of medicine | 2010 | PMID: 21190454 |
Chronic granulomatous disease caused by mutations other than the common GT deletion in NCF1, the gene encoding the p47phox component of the phagocyte NADPH oxidase. | Roos D | Human mutation | 2006 | PMID: 16972229 |
Autosomal recessive chronic granulomatous disease caused by defects in NCF-1, the gene encoding the phagocyte p47-phox: mutations not arising in the NCF-1 pseudogenes. | Noack D | Blood | 2001 | PMID: 11133775 |
Recombination events between the p47-phox gene and its highly homologous pseudogenes are the main cause of autosomal recessive chronic granulomatous disease. | Roesler J | Blood | 2000 | PMID: 10706888 |
A p47-phox pseudogene carries the most common mutation causing p47-phox- deficient chronic granulomatous disease. | Görlach A | The Journal of clinical investigation | 1997 | PMID: 9329953 |
In vitro molecular reconstitution of the respiratory burst in B lymphoblasts from p47-phox-deficient chronic granulomatous disease. | Volpp BD | The Journal of clinical investigation | 1993 | PMID: 7678602 |
Autosomal recessive chronic granulomatous disease caused by deletion at a dinucleotide repeat. | Casimir CM | Proceedings of the National Academy of Sciences of the United States of America | 1991 | PMID: 2011585 |
Chronic granulomatous disease: studies of a family with impaired neutrophil chemotactic, metabolic and bactericidal function. | Clark FA | The American journal of medicine | 1978 | PMID: 742630 |
Text-mined citations for rs4029402 ...
HelpRecord last updated Oct 20, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.